ARTLVSNIVF• 6 Months (Normalized)
ARTL vs NIVF (Artelo Biosciences Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-92.37%
Artelo Biosciences Inc.
Normalized Baseline0.00%
NIVF Performance $0.59
+%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin NIVF LEADS
-92.37 pts
NIVF outperforming by 92.37 percentage points
ARTLNIVF
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(121 dates)
| Date | ARTL Price | ARTL Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -92.37% | $- | - | |
| Sep 24, 2026 | $5.17 | -91.31% | $- | - | |
| Sep 23, 2026 | $7.31 | -87.71% | $0.59 | -96.92% | +9.21% |
| Sep 22, 2026 | $4.15 | -93.02% | $0.73 | -96.17% | +3.15% |
| Sep 21, 2026 | $4.10 | -93.11% | $0.72 | -96.24% | +3.13% |
| Sep 18, 2026 | $3.94 | -93.38% | $0.72 | -96.25% | +2.87% |
| Sep 17, 2026 | $3.97 | -93.33% | $0.72 | -96.27% | +2.94% |
| Sep 16, 2026 | $3.75 | -93.70% | $0.79 | -95.91% | +2.21% |
| Sep 15, 2026 | $5.34 | -91.02% | $0.84 | -95.62% | +4.60% |
| Sep 14, 2026 | $4.87 | -91.81% | $0.93 | -95.15% | +3.34% |
| Sep 11, 2026 | $5.43 | -90.87% | $1.06 | -94.47% | +3.60% |
| Sep 10, 2026 | $5.63 | -90.54% | $1.11 | -94.21% | +3.67% |
| Sep 09, 2026 | $5.98 | -89.95% | $1.10 | -94.26% | +4.31% |
| Sep 08, 2026 | $6.19 | -89.59% | $1.11 | -94.21% | +4.62% |
| Sep 04, 2026 | $6.04 | -89.85% | $1.14 | -94.05% | +4.20% |
Page 1 of 9